Federal legislators failed to act on the rising tide of anti-PBM sentiment in 2024, but health policy experts predict that the risk of regulatory intervention will ramp up this year even with Republicans, who traditionally are viewed as business friendly, controlling Congress and the White House.
This Year, PBM-Directed Fury May Once Again Signify Nothing
Anti-PBM sentiment continues to rise, but industry observers still question whether the reforms being discussed will be effective.
